Chlorhexidine spray to prevent radiation skin damage in throat cancer
Part of Cancer, Skin clinical trials.
This study tests whether a chlorhexidine spray (an antiseptic liquid) can prevent or reduce skin damage caused by radiation therapy in people being treated for nasopharyngeal cancer (cancer in the back of the nose/throat). Radiation dermatitis—painful redness and irritation of the skin—is a common side effect, and this spray may help protect your skin during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with nasopharyngeal carcinoma (cancer in the back of the nose) confirmed by biopsy or cell sample
- Stage II or III cancer with lymph node involvement (N≥1)
- Planning to receive radiation therapy plus chemotherapy as your first cancer treatment
- Radiation dose will be 60–70 Gy (standard for this cancer type)
- No allergy or sensitivity to chlorhexidine (the active ingredient in the spray)
- No other skin conditions, active cancer elsewhere, or severe health problems that would interfere with the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a way to adjust radiation therapy to better protect the thyroid gland during treatment for nasopharyngeal carcinoma. It aims to reduce thyroid damage while still effectively treating the cancer.
This study tests whether a special skin spray can prevent radiation burns during head and neck cancer treatment. It may help reduce pain and skin damage from radiation therapy.
This trial tests whether applying fluoride to teeth before and during radiation therapy can help prevent cavities caused by the treatment. It is designed for people with nasopharyngeal cancer who are about to receive radiation to their head and neck area.
This trial compares a new radiation technique designed to reduce dry mouth (xerostomia) with standard radiation for people with nasopharyngeal cancer. It aims to see if the new approach can protect saliva glands while still treating the cancer effectively.
This trial tests whether a taurine mouthwash can prevent or reduce the severity of painful mouth sores caused by radiation therapy for nasopharyngeal cancer. If it works, it could make treatment more tolerable and improve quality of life.
This trial tests whether a traditional Chinese medicine mouthwash and oral liquid can help prevent or reduce mouth sores caused by radiation therapy for head and neck cancer. If you are getting radiation and are at risk for these painful sores, this study might offer you extra relief.
Hear when a new Nasopharangeal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.